Keck School Faculty

Quynh Le
Quynh Le
Clinical Instructor of Surgery (Fellow)
1520 San Pablo Street Health Sciences Campus Los Angeles

Retraction Note: Lysyl oxidase is essential for hypoxia-induced metastasis Nature. 2020 03; 579(7799):456. . View in PubMed

The role of Glial cell derived neurotrophic factor in head and neck cancer PLoS One. 2020; 15(2):e0229311. . View in PubMed

Nasopharyngeal carcinoma Lancet. 2019 Jul 06; 394(10192):64-80. . View in PubMed

Increased Galectin-1 Expression in Thymic Epithelial Tumors Clin Lung Cancer. 2019 05; 20(3):e356-e361. . View in PubMed

Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance J Clin Invest. 2019 12 02; 129(12):5553-5567. . View in PubMed

International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma Int J Radiat Oncol Biol Phys. 2019 11 01; 105(3):567-580. . View in PubMed

Adaptive radiotherapy for head and neck cancer: Are we ready to put it into routine clinical practice? Oral Oncol. 2018 11; 86:19-24.. View in PubMed

International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma Radiother Oncol. 2018 01; 126(1):25-36. . View in PubMed

SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells Clin Cancer Res. 2017 Sep 01; 23(17):5162-5175. . View in PubMed

Clinical Utility of Epstein-Barr Virus DNA Testing in the Treatment of Nasopharyngeal Carcinoma Patients Int J Radiat Oncol Biol Phys. 2017 08 01; 98(5):996-1001. . View in PubMed

Clinical Outcomes in Elderly Patients Treated for Oral Cavity Squamous Cell Carcinoma Int J Radiat Oncol Biol Phys. 2017 07 15; 98(4):775-783. . View in PubMed

Botulinum Toxin Confers Radioprotection in Murine Salivary Glands Int J Radiat Oncol Biol Phys. 2016 Apr 01; 94(5):1190-7. . View in PubMed

Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy Cancer. 2016 Feb 15; 122(4):546-58. . View in PubMed

Survival benefit for adjuvant radiation therapy in minor salivary gland cancers Oral Oncol. 2015 May; 51(5):438-45. . View in PubMed

Concurrent cetuximab versus platinum-based chemoradiation for the definitive treatment of locoregionally advanced head and neck cancer Head Neck. 2015 Mar; 37(3):386-92. . View in PubMed

p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma J Clin Oncol. 2014 Dec 10; 32(35):3930-8. . View in PubMed

CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma Oncotarget. 2014 Aug 30; 5(16):6854-66. . View in PubMed

Neurotrophic factor GDNF promotes survival of salivary stem cells J Clin Invest. 2014 Aug; 124(8):3364-77. . View in PubMed

Salvage treatment for locally recurrent nasopharyngeal carcinoma (NPC) Am J Clin Oncol. 2014 Aug; 37(4):327-31. . View in PubMed

Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patients Head Neck. 2014 May; 36(5):709-14. . View in PubMed

Discovery of recurrent structural variants in nasopharyngeal carcinoma Genome Res. 2014 Feb; 24(2):300-9. . View in PubMed

Radiologic assessment of retropharyngeal node involvement in oropharyngeal carcinomas stratified by HPV status Radiother Oncol. 2013 Nov; 109(2):293-6. . View in PubMed

Long-term outcomes of surgery followed by radiation therapy for minor salivary gland carcinomas Laryngoscope. 2013 Nov; 123(11):2675-80. . View in PubMed

A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growth Clin Cancer Res. 2013 Aug 15; 19(16):4455-64. . View in PubMed

An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma Clin Cancer Res. 2013 Apr 15; 19(8):2208-15. . View in PubMed

Results of a phase 2 study examining the effects of omitting elective neck irradiation to nodal levels IV and Vb in patients with N(0-1) nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):929-34. . View in PubMed

Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's disease Inflamm Bowel Dis. 2013 Jan; 19(1):30-6. . View in PubMed

Loss of the p53/p63 target PERP is an early event in oral carcinogenesis and correlates with higher rate of local relapse Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jan; 115(1):95-103. . View in PubMed

CD44(+) cells have cancer stem cell-like properties in nasopharyngeal carcinoma Int Forum Allergy Rhinol. 2012 Nov; 2(6):465-70. . View in PubMed

Validation that metabolic tumor volume predicts outcome in head-and-neck cancer Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):1514-20. . View in PubMed

Evaluation of ProExC as a prognostic marker in oropharyngeal squamous cell carcinomas Am J Surg Pathol. 2012 Aug; 36(8):1158-64. . View in PubMed

Prognostic and predictive significance of plasma HGF and IL-8 in a phase III trial of chemoradiation with or without tirapazamine in locoregionally advanced head and neck cancer Clin Cancer Res. 2012 Mar 15; 18(6):1798-807. . View in PubMed

Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patients Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):e351-8. . View in PubMed

Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial Lancet Oncol. 2012 Feb; 13(2):172-80. . View in PubMed

A novel aldehyde dehydrogenase-3 activator leads to adult salivary stem cell enrichment in vivo Clin Cancer Res. 2011 Dec 01; 17(23):7265-72. . View in PubMed

Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity Radiother Oncol. 2011 Dec; 101(3):356-61. . View in PubMed

Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis Cancer Res. 2011 Jul 01; 71(13):4423-31. . View in PubMed

MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation Am J Surg Pathol. 2011 Jan; 35(1):92-9. . View in PubMed

The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways PLoS One. 2010 Mar 10; 5(3):e9633. . View in PubMed

Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03 J Clin Oncol. 2009 Sep 10; 27(26):4281-6. . View in PubMed

The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas Int J Radiat Oncol Biol Phys. 2009 Jun 01; 74(2):553-61. . View in PubMed

Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas Int J Radiat Oncol Biol Phys. 2007 Sep 01; 69(1):167-75. . View in PubMed

Lysyl oxidase is essential for hypoxia-induced metastasis Nature. 2006 Apr 27; 440(7088):1222-6. . View in PubMed

An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers Clin Cancer Res. 2006 Mar 01; 12(5):1507-14. . View in PubMed

Galectin-1: a link between tumor hypoxia and tumor immune privilege J Clin Oncol. 2005 Dec 10; 23(35):8932-41. . View in PubMed

A noninvasive approach for assessing tumor hypoxia in xenografts: developing a urinary marker for hypoxia Cancer Res. 2005 Jul 15; 65(14):6151-8. . View in PubMed

Identification of hypoxia-regulated proteins in head and neck cancer by proteomic and tissue array profiling Cancer Res. 2004 Oct 15; 64(20):7302-10. . View in PubMed

XBP1 is essential for survival under hypoxic conditions and is required for tumor growth Cancer Res. 2004 Sep 01; 64(17):5943-7. . View in PubMed

Powered by SC CTSI
Go to Top